Cargando…

Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer’s Disease: the Receptor for Advanced Glycation End Products (RAGE)

Diabetes and Alzheimer’s disease (AD) place a significant burden on health care systems in the world and its aging populations. These diseases have long been regarded as separate entities; however, advanced glycation end products (AGEs) and the receptors for AGEs (RAGE) may be a link between diabete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Yanyan, Wang, Fushuai, Wang, Jiao, Liu, Cuiping, Zhou, Yinping, Xu, Zhengqin, Zhang, Chencheng, Sun, Bomin, Guan, Yihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388912/ https://www.ncbi.nlm.nih.gov/pubmed/32774301 http://dx.doi.org/10.3389/fnagi.2020.00217

Ejemplares similares

Progress of RAGE Molecular Imaging in Alzheimer’s Disease
por: Kong, Yanyan, et al.
Publicado: (2020)

PET Imaging of Neutrophils Infiltration in Alzheimer's Disease Transgenic Mice
por: Kong, Yanyan, et al.
Publicado: (2020)

The Synaptic Vesicle Protein 2A Interacts With Key Pathogenic Factors in Alzheimer’s Disease: Implications for Treatment
por: Kong, Yanyan, et al.
Publicado: (2021)

Elucidating the Relationship Between Diabetes Mellitus and Parkinson’s Disease Using (18)F-FP-(+)-DTBZ, a Positron-Emission Tomography Probe for Vesicular Monoamine Transporter 2
por: Kong, Yanyan, et al.
Publicado: (2020)

The Receptor for Advanced Glycation End Products (RAGE) and the Lung
por: Buckley, Stephen T., et al.
Publicado: (2010)

The Role of Receptor for Advanced Glycation End Products (RAGE) in the Proliferation of Hepatocellular Carcinoma
por: Yaser, Al-Madhagi, et al.
Publicado: (2012)

Role of receptor for advanced glycation end products (RAGE) in liver disease
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015)

Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
por: Taneja, Sakshi, et al.
Publicado: (2021)

Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients
por: Lazzari, Tássia Kirchmann, et al.
Publicado: (2021)

The Potential Influence of Advanced Glycation End Products and (s)RAGE in Rheumatic Diseases
por: Delrue, Charlotte, et al.
Publicado: (2023)

Imaging of dopamine transporters in Parkinson disease: a meta‐analysis of (18)F/(123)I‐FP‐CIT studies
por: Kong, Yanyan, et al.
Publicado: (2020)

Positron Emission Computed Tomography Imaging of Synaptic Vesicle Glycoprotein 2A in Alzheimer’s Disease
por: Kong, Yanyan, et al.
Publicado: (2021)

The Receptor for Advanced Glycation End Products (RAGE) Contributes to the Progression of Emphysema in Mice
por: Sambamurthy, Nisha, et al.
Publicado: (2015)

The Receptor for Advanced Glycation End Products (RAGE) Is Associated with Persistent Atrial Fibrillation
por: Lancefield, Terase F., et al.
Publicado: (2016)

Receptor for advanced glycation end-products (RAGE) mediates phagocytosis in nonprofessional phagocytes
por: Yang, Yan, et al.
Publicado: (2022)

Receptor for the Advanced Glycation End Products (RAGE) Pathway in Adipose Tissue Metabolism
por: Gutowska, Klaudia, et al.
Publicado: (2023)

Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE Ligands
por: Yao, Dachun, et al.
Publicado: (2010)

Polymorphisms −374 T/A and −429 T/C of the Receptor for Advanced Glycation End-Products (RAGE) and Serum Levels of RAGE (sRAGE) Are Not Associated with Metabolic Syndrome
por: González-Guerrero, Diana Elizabeth, et al.
Publicado: (2023)

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
por: Caldiroli, Lara, et al.
Publicado: (2022)

Advanced glycation end products correlate with breast cancer metastasis by activating RAGE/TLR4 signaling
por: Pan, Shuo, et al.
Publicado: (2022)

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
por: Soro-Paavonen, Aino, et al.
Publicado: (2008)

The Receptor for Advanced Glycation End Products (RAGE) Specifically Recognizes Methylglyoxal-Derived AGEs
por: Xue, Jing, et al.
Publicado: (2014)

Characterization of advanced glycation end products and their receptor (RAGE) in an animal model of myocardial infarction
por: Fracasso, Bianca de Moraes, et al.
Publicado: (2019)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
por: Pratte, Katherine A., et al.
Publicado: (2021)

Dysregulation of Receptor for Advanced Glycation End Products (RAGE) Expression as a Biomarker of Keratoconus
por: Navel, Valentin, et al.
Publicado: (2022)

Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases
por: Yue, Qing, et al.
Publicado: (2022)

RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
por: Sparvero, Louis J, et al.
Publicado: (2009)

Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress
por: Wei, Qin, et al.
Publicado: (2013)

Receptor for Advanced Glycation End Products (RAGE) and Its Ligands: Focus on Spinal Cord Injury
por: Song, Juhyun, et al.
Publicado: (2014)

The Receptor for Advanced Glycation End Products (RAGE) Affects T Cell Differentiation in OVA Induced Asthma
por: Akirav, Eitan M., et al.
Publicado: (2014)

Advanced glycation end products (AGEs) and their receptor (RAGE) induce apoptosis of periodontal ligament fibroblasts
por: Li, D.X., et al.
Publicado: (2014)

Relevance of Receptor for Advanced Glycation end Products (RAGE) in Murine Antibody-Mediated Autoimmune Diseases
por: Eichhorst, Alexandra, et al.
Publicado: (2019)

Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging
por: Scavello, Francesco, et al.
Publicado: (2019)

Characterization of αX I-Domain Binding to Receptors for Advanced Glycation End Products (RAGE)
por: Buyannemekh, Dolgorsuren, et al.
Publicado: (2017)

Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors
por: Singh, Harbinder, et al.
Publicado: (2022)

Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions
por: Koerich, Suélyn, et al.
Publicado: (2023)

Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH)
por: Mehta, Rohini, et al.
Publicado: (2018)

The Remarkable Roles of the Receptor for Advanced Glycation End Products (RAGE) and Its Soluble Isoforms in COVID-19: The Importance of RAGE Pathway in the Lung Injuries
por: Salehi, Mitra, et al.
Publicado: (2022)

G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer’s disease pathology
por: C, Rani Cathrine., et al.
Publicado: (2020)

SUN-LB131 Association of Receptor for Advanced Glycation End Product (RAGE) Gene Polymorphisms & Serum Levels of Soluble RAGE (sRAGE) With Metabolic Syndrome (MS) in Mexican Population
por: Gonzalez-Guerrero, Diana Elizabeth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_th4lnlvbudvedfcl2octo9sqbj